RxDoctor Payments Data

Janaki Nadarajah, DPM

Podiatrist · Martinez, GANPI 1831288018

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $887 of the $1,380 with a category attached, or 64.3%. 20 manufacturers reported payments, led by Welch Allyn at 35.7% of the total. Reporting peaked in 2021 at $606 and has fallen 82.3% since, to $107 in 2025. That places this record below the midpoint for podiatrist clinicians in GA, where the typical reported total is $1,116.

$1,380in general payments, 2019–2025

Across 42 payments — averaging $32.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Welch Allyn$493
  • AbbVie$140
  • Averitas Pharma Inc.$122
  • GRT US Holding, Inc.$94
  • Cook Medical LLC$84
  • Smith+Nephew$73
  • plus $375 from 14 others
$207,087in research payments, 2019–2025

Across 229 payments — averaging $904.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$113K
  • Cleerly, Inc.$94K

What the payments were for

  • Food & beverage$88764%
  • Other$49336%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,380 in reported general payments places this provider in the 50th percentile of 177 podiatrist providers in Georgia.

See all podiatrist providers in Georgia

Medicare billing

Part B allowed, 2024
$57,204
Medicare patients
109
Services billed
580

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other podiatrist in Martinez

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →